PAH Compounds

Hazard index for receptor, route and chemical

Carcinogenic risk for receptor, route and chemical

Resident CTE

Child

Adult

Child

Adult

 

Ingestion

 

 

Dermal

 

Total

 

Ingestion

 

 

Dermal

 

Total

 

Ingestion

 

 

Dermal

 

Total

 

Ingestion

 

 

Dermal

 

Total

 

Anthracene

 

2.58×10-6

 

5.08×10-7

 

3.09×10-6

 

7.58×10-8

 

7.67×10-8

 

1.53×10-7

 

-

 

-

 

-

 

-

 

-

 

-

 

Naphthalene

 

3.00×10-3

 

5.90×10-4

 

3.59×10-3

 

8.80×10-5

 

8.90×10-5

 

1.77×10-4

 

-

 

-

 

-

 

-

 

-

 

-

 

Pyrene

 

1.24×10-5

 

2.43×10-6

 

1.48×10-5

 

3.63×10-7

 

3.68×10-7

 

7.31×10-7

 

-

 

-

 

-

 

-

 

-

 

-

 

Fluorene

 

5.29×10-7

 

1.04×10-7

 

6.33×10-7

 

1.55×10-8

 

1.57×10-8

 

3.12×10-8

 

-

 

-

 

-

 

-

 

-

 

-

 

Benzo(b)fluoranthene

 

-

 

-

 

-

 

-

 

-

 

-

 

1.22×10-6

 

2.39×10-7

 

1.46×10-6

 

5.34×10-8

 

5.41×10-8

 

1.08×10-7

 

Total

 

3.02×10-3

 

5.93×10-4

 

3.61×10-3

 

3.00×10-3

 

8.95×10-5

 

3.09×10-3

 

1.22×10-6

 

2.39×10-7

 

1.46×10-6

 

5.34×10-8

 

5.41×10-8

 

1.08×10-7

 

 

Resident RME

 

 

 

 

Anthracene

 

1.55×10-5

 

6.19×10-6

 

2.17×10-5

 

1.66×10-6

 

1.91×10-6

 

3.57×10-6

-

-

-

-

-

-

 

Naphthalene

 

1.80×10-2

 

7.19×10-3

 

2.52×10-2

 

1.92×10-3

 

2.21×10-3

 

4.13×10-3

-

-

-

-

-

-

 

Pyrene

 

7.42×10-5

 

2.97×10-5

 

1.04×10-4

 

7.95×10-6

 

9.14×10-6

 

1.71×10-5

-

-

-

-

-

-

 

Fluorene

 

3.16×10-5

 

1.27×10-5

 

4.43×10-5

 

3.39×10-6

 

3.90×10-6

 

7.29×10-6

-

-

-

-

-

-

 

Benzo(b)fluoranthene

 

-

 

-

 

-

 

-

 

-

 

-

 

7.27×10-6

 

2.91×10-6

 

1.02×10-5

 

3.90×10-6

 

4.48×10-6

 

8.38×10-6

 

Total

 

1.81×10-2

 

7.24×10-3

 

2.54×10-2

 

1.93×10-3

 

2.22×10-3

 

4.16×10-3

 

7.27×10-6

 

2.91×10-6

 

1.02×10-5

 

3.90×10-6

 

4.48×10-6

 

8.38×10-6

Table 8: Carcinogenic and non-carcinogenic risk values for PAHs via CTE and RME Scenarios.